Foamy viruses

Fields Virology: Sixth Edition

Volumn 1, Issue , 2013, Pages

  Rethwilm, Axel ^a   Lindemann, Dirk ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84974693434     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (283)

1. Achong BG, Mansell PW, Epstein MA, et al. An unusual virus in cultures from a human nasopharyngeal carcinoma. J Natl Cancer Inst 1971;46:299-307.
2. Ali M, Taylor GP, Pitman RJ, et al. No evidence of antibody to human foamy virus in widespread human populations. AIDS Res Hum Retroviruses 1996;12:1473-1483.
3. Alke A, Schwantes A, Kido K, et al. The bet gene of feline foamy virus is required for virus replication. Virology 2001;287:310-320.
4. Allan JS, Broussard SR, Michaels MG, et al. Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Res Hum Retroviruses 1998;14:821-824.
5. Amborski GF, Storz J, Keney D, et al. Isolation of a retrovirus from the American bison and its relation to bovine retroviruses. J Wildl Dis 1987;23:7-11.
6. An DG, Hyun U, Shin CG. Characterization of nuclear localization signals of the prototype foamy virus integrase. J Gen Virol 2008;89:1680-1684.
7. Baldwin DN, Linial ML. The roles of Pol and Env in the assembly pathway of human foamy virus. J Virol 1998;72:3658-3665.
8. Bandecchi P, Matteucci D, Baldinotti F, et al. Prevalence of feline immunodeficiency virus and other retroviral infections in sick cats in Italy. Vet Immunol Immunopathol 1992;31:337-345.
9. Bauer TR, Jr, Allen JM, Hai M, et al. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 2008;14:93-97.
10. Baunach G, Maurer B, Hahn H, et al. Functional analysis of human foamy virus accessory reading frames. J Virol 1993;67:5411-5418.
11. Bennett RP, Rhee S, Craven RC, et al. Amino acids encoded downstream of gag are not required by Rous sarcoma virus protease during gag-mediated assembly. J Virol 1991;65:272-280.
12. Berg A, Pietschmann T, Rethwilm A, et al. Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection. Virology 2003;314:243-252.
13. Bieniasz PD, Weiss RA, McClure MO. Cell cycle dependence of foamy retrovirus infection. J Virol 1995;69:7295-7299.
14. Blair WS, Bogerd H, Cullen BR. Genetic analysis indicates that the human foamy virus Bel-1 protein contains a transcription activation domain of the acidic class. J Virol 1994;68:3803-3808.
15. Bock M, Heinkelein M, Lindemann D, et al. Cells expressing the human foamy virus (HFV) accessory Bet protein are resistant to productive HFV superinfection. Virology 1998;250:194-204.
16. Bodem J. Würzburg, Germany. Personal communication.
17. Bodem J. Regulation of foamy virus transcription and RNA export. Adv Virus Res 2011;81:1-31.
18. Bodem J, Kang Y, Flügel RM. Comparative functional characterization of the feline foamy virus transactivator reveals its species specificity. Virology 2004;318:32-36.
19. Bodem J, Kräusslich HG, Rethwilm A. Acetylation of the foamy virus transactivator Tas by PCAF augments promoter-binding affinity and virus transcription. J Gen Virol 2007;88:259-263.
20. Bodem J, Löchelt M, Delius H, et al. Detection of subgenomic cDNAs and mapping of feline foamy virus mRNAs reveals complex patterns of transcription. Virology 1998;244:417-426.
21. Bodem J, Löchelt M, Winkler I, et al. Characterization of the spliced pol transcript of feline foamy virus: the splice acceptor site of the pol transcript is located in gag of foamy viruses. J Virol 1996;70:9024-9027.
22. Bodem J, Schied T, Gabriel R, et al. Foamy virus nuclear RNA export is distinct from that of other retroviruses. J Virol 2011;85:2333-2341.
23. Boneva RS, Switzer WM, Spira TJ, et al. Clinical and virological characterization of persistent human infection with simian foamy viruses. AIDS Res Hum Retroviruses 2007;23:1330-1337.
24. Boyer PL, Stenbak CR, Clark PK, et al. Characterization of the polymerase and RNase H activities of human foamy virus reverse transcriptase. J Virol 2004;78:6112-6121.
25. Boyer PL, Stenbak CR, Hoberman D, et al. In vitro fidelity of the prototype primate foamy virus (PFV) RT compared to HIV-1 RT. Virology 2007;367:253-264.
26. Brooks JI, Merks HW, Fournier J, et al. Characterization of blood-borne transmission of simian foamy virus. Transfusion 2007;47:162-170.
27. Brown P, Moreau-Dubois MC, Gajdusek DC. Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retrovirus latency. Arch Virol 1982;71:229-234.
28. Brown PO. Integration. In: Coffin JM, Hughes SH, Varmus HE, eds. Retroviruses. Cold Spring Harbor: Cold Spring Harbor Laboratory Press; 1997:161-203.
29. Butera ST, Brown J, Callahan ME, et al. Survey of veterinary conference attendees for evidence of zoonotic infection by feline retroviruses. J Am Vet Med Assoc 2000;217:1475-1479.
30. Cain D, Erlwein O, Grigg A, et al. Palindromic sequence plays a critical role in human foamy virus dimerization. J Virol 2001;75:3731-3739.
31. Calattini S, Betsem EB, Froment A, et al. Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg Infect Dis 2007;13:1314-1320.
32. Calattini S, Wanert F, Thierry B, et al. Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeana colony. Retrovirology 2006;3:23.
33. Cartellieri M, Herchenröder O, Rudolph W, et al. N-terminal Gag domain required for foamy virus particle assembly and export. J Virol 2005;79:12464-12476.
34. Cartellieri M, Rudolph W, Herchenröder O, et al. Determination of the relative amounts of Gag and Pol proteins in foamy virus particles. Retrovirology 2005;2:44.
35. Chang J, Lee KJ, Jang KL et al. Human foamy virus Bel1 transactivator contains a bipartite nuclear localization determinant which is sensitive to protein context and triple multimerization domains. J Virol 1995;69:801-808.
36. Chang R, Tan J, Xu F, et al. Lysine acetylation sites in bovine foamy virus transactivator BTas are important for its DNA binding activity. Virology 2011;418:21-26.
37. Chareza S, Slavkovic Lukic D, Räthe A-M, et al. Molecular and functional interactions of cat APOBEC3 and feline foamy and immunodeficiency virus proteins: different ways to counteract host-encoded restriction. Virology 2012;242(2):138-146.
38. Cherepanov P, Maertens GN, Hare S. Structural insights into the retroviral DNA integration apparatus. Curr Opin Struct Biol 2011;21:249-256.
39. Cullen BR. Nuclear RNA export. J Cell Sci 2003;116:587-597.
40. Cullen BR. Retroviruses as model systems for the study of nuclear RNA export pathways. Virology 1998;249:203-210.
41. Debons-Guillemin MC, Valla J, Gazeau J, et al. No evidence of spumaretrovirus infection markers in 19 cases of De Quervain's thyroiditis. AIDS Res Hum Retroviruses 1992;8:1547.
42. Delebecque F, Suspene R, Calattini S, et al. Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol 2006;80:605-614.
43. Delelis O, Saïb A, Sonigo P. Biphasic DNA synthesis in spumaviruses. J Virol 2003;77:8141-8146.
44. Deyle DR, Li Y, Olson EM, et al. Nonintegrating foamy virus vectors. J Virol 2010;84:9341-9349.
45. Duda A, Lüftenegger D, Pietschmann T, et al. Characterization of the prototype foamy virus envelope glycoprotein receptor-binding domain. J Virol 2006;80:8158-8167.
46. Duda A, Stange A, Lüftenegger D et al. Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivity. J Virol 2004;78:13865-13870.
47. Eastman SW, Linial ML. Identification of a conserved residue of foamy virus Gag required for intracellular capsid assembly. J Virol 2001;75:6857-6864.
48. Enders JF, Peebles TC. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 1954;86:277-286.
49. Enssle J, Fischer N, Moebes A, et al. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle. J Virol 1997;71:7312-7317.
50. Enssle J, Jordan I, Mauer B, et al. Foamy virus reverse transcriptase is expressed independently from the Gag protein. Proc Natl Acad Sci U S A 1996;93:4137-4141.
51. Enssle J, Moebes A, Heinkelein M, et al. An active foamy virus integrase is required for virus replication. J Gen Virol 1999;80:1445-1452.
52. Epstein MA. Simian retroviral infections in human beings. Lancet 2004;364:137-140.
53. Erlwein O, Bieniasz PD, McClure MO. Sequences in pol are required for transfer of human foamy virus-based vectors. J Virol 1998;72:5510-5516.
54. Erlwein O, Cain D, Fischer N, et al. Identification of sites that act together to direct dimerization of human foamy virus RNA in vitro. Virology 1997;229:251-258.
55. Falcone V, Leupold J, Clotten J, et al. Sites of simian foamy virus persistence in naturally infected African green monkeys: latent provirus is ubiquitous, whereas viral replication is restricted to the oral mucosa. Virology 1999;257:7-14.
56. Falcone V, Schweizer M, Neumann-Haefelin D. Replication of primate foamy viruses in natural and experimental hosts. Curr Top Microbiol Immunol 2003;277:161-180.
57. Falcone V, Schweizer M, Toniolo A, et al. Gamma interferon is a major suppressive factor produced by activated human peripheral blood lymphocytes that is able to inhibit foamy virus-induced cytopathic effects. J Virol 1999;73:1724-1728.
58. Felsenstein KM, Goff SP. Expression of the gag-pol fusion protein of Moloney murine leukemia virus without gag protein does not induce virion formation or proteolytic processing. J Virol 1988;62:2179-2182.
59. Fischer N, Heinkelein M, Lindemann D, et al. Foamy virus particle formation. J Virol 1998;72:1610-1615.
60. Flanagan M. Isolation of a spumavirus from a sheep. Aust Vet J 1992;69:112-113.
61. Flügel RM, Pfrepper KI. Proteolytic processing of foamy virus Gag and Pol proteins. Curr Top Microbiol Immunol 2003;277:63-88.
62. Fütterer J, Kiss-Laszlo Z, Hohn T. Nonlinear ribosome migration on cauliflower mosaic virus 35S RNA. Cell 1993;73:789-802.
63. Gärtner K, Wiktorowicz T, Park J, et al. Accuracy estimation of foamy virus genome copying. Retrovirology 2009;6:32.
64. Geiselhart V, Bastone P, Kempf T, et al. Furin-mediated cleavage of the feline foamy virus Env leader protein. J Virol 2004;78:13573-13581.
65. Geiselhart V, Schwantes A, Bastone P, et al. Features of the Env leader protein and the N-terminal Gag domain of feline foamy virus important for virus morphogenesis. Virology 2003;310:235-244.
66. Gessain A. Paris, personal communication.
67. Gharwan H, Hirata RK, Wang P, et al. Transduction of human embryonic stem cells by foamy virus vectors. Mol Ther 2007;15:1827-1833.
68. Giron ML, Colas S, Wybier J, et al. Expression and maturation of human foamy virus Gag precursor polypeptides. J Virol 1997;71:1635-1639.
69. Giron ML, de The H, Saib A. An evolutionarily conserved splice generates a secreted env-Bet fusion protein during human foamy virus infection. J Virol 1998;72:4906-4910.
70. Goebel WS. Protocol #1104-1105: A phase I/II study of lentiviral gene transfer for the treatment of fanconi anemia type A. Indianapolis: Indiana University School of Medicine; 2011.
71. Goepfert PA, Shaw KL, Ritter GD, Jr, et al. A sorting motif localizes the foamy virus glycoprotein to the endoplasmic reticulum. J Virol 1997;71:778-784.
72. Goepfert PA, Shaw KL, Wang G, et al. An endoplasmic reticulum retrieval signal partitions human foamy virus maturation to intracytoplasmic membranes. J Virol 1999;73:7210-7217.
73. Hahn H, Baunach G, Bräutigam S, et al. Reactivity of primate sera to foamy virus Gag and Bet proteins. J Gen Virol 1994;75:2635-2644.
74. Han GZ, Worobey M. An endogenous foamy virus in the aye-aye (Daubentonia madagascariensis). J Virol 2012;86:7696-7698.
75. Han GZ, Worobey M. An endogenous foamy-like viral element in the Coelacanth genome. PLoSPath 2012;8:e1002790.
76. Hare S, Gupta SS, Valkov E, et al. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 2010;464:232-236.
77. Hare S, Smith SJ, Metifiot M, et al. Structural and functional analyses of the second-generation integrase strand transfer inhibitor dolutegravir (S/GSK1349572). Mol Pharmacol 2011;80:565-572.
78. Hare S, Vos AM, Clayton RF, et al. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc Natl Acad Sci U S A 2010;107:20057-20062.
79. Hartl MJ, Bodem J, Jochheim F, et al. Regulation of foamy virus protease activity by viral RNA-a novel and unique mechanism among retroviruses. J Virol 2011;85:4462-4469.
80. Hartl MJ, Schweimer K, Reger MH, et al. Formation of transient dimers by a retroviral protease. Biochem J 2010;427:197-203.
81. He F, Blair WS, Fukushima J, et al. The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein. J Virol 1996;70:3902-3908.
82. Heberling RL, Kalter SS. Isolation of foamy viruses from baboon (Papio cynocephalus) tissues. Am J Epidemiol 1975;102:25-29.
83. Heinkelein M, Leurs C, Rammling M, et al. Pregenomic RNA is required for efficient incorporation of pol polyprotein into foamy virus capsids. J Virol 2002;76:10069-10073.
84. Heinkelein M, Pietschmann T, Jarmy G, et al. Efficient intracellular retrotransposition of an exogenous primate retrovirus genome. EMBO J 2000;19:3436-3445.
85. Heinkelein M, Rammling M, Juretzek T, et al. Retrotransposition and cell-to-cell transfer of foamy viruses. J Virol 2003;77:11855-11858.
86. Heinkelein M, Schmidt M, Fischer N, et al. Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. J Virol 1998;72:6307-6314.
87. Helps CR, Harbour DA. Comparison of the complete sequence of feline spumavirus with those of the primate spumaviruses reveals a shorter gag gene. J Gen Virol 1997;78:2549-2564.
88. Hendrie PC, Huo Y, Stolitenko RB, et al. A rapid and quantitative assay for measuring neighboring gene activation by vector proviruses. Mol Ther 2008;16:534-540.
89. Heneine W, Kuehnert MJ. Preserving blood safety against emerging retroviruses. Transfusion 2006;46:1276-1278.
90. Heneine W, Musey VC, Sinha SD et al. Absence of evidence for human spumaretrovirus sequences in patients with Graves' disease. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:99-101.
91. Heneine W, Switzer WM, Sandstrom P, et al. Identification of a human population infected with simian foamy viruses. Nat Med 1998;4:403-407.
92. Herchenröder O, Renne R, Loncar D, et al. Isolation, cloning, and sequencing of simian foamy viruses from chimpanzees (SFVcpz): high homology to human foamy virus (HFV). Virology 1994;201:187-199.
93. Hill CL, Bieniasz PD, McClure MO. Properties of human foamy virus relevant to its development as a vector for gene therapy. J Gen Virol 1999;80:2003-2009.
94. Hirata RK, Miller AD, Andrews RG, et al. Transduction of hematopoietic cells by foamy virus vectors. Blood 1996;88:3654-3661.
95. Hohn T, Corsten S, Dominguez D, et al. Shunting is a translation strategy used by plant pararetroviruses (Caulimoviridae). Micron 2001;32:51-57.
96. Holzschu DL, Delaney MA, Renshaw RW, et al. The nucleotide sequence and spliced pol mRNA levels of the nonprimate spumavirus bovine foamy virus. J Virol 1998;72:2177-2182.
97. Hooks JJ, Detrick-Hooks B. Simian foamy virus-induced immunosuppression in rabbits. J Gen Virol 1979;44:383-390.
98. Hooks JJ, Gibbs CJ, Jr. The foamy viruses. Bacteriol Rev 1975;39:169-185.
99. Hooks JJ, Gibbs CJ, Jr, Cutchins EC, et al. Characterization and distribution of two new foamy viruses isolated from chimpanzees. Arch Gesamte Virusforsch 1972;38:38-55.
100. Hussain AI, Shanmugam V, Bhullar VB, et al. Screening for simian foamy virus infection by using a combined antigen Western blot assay: evidence for a wide distribution among Old World primates and identification of four new divergent viruses. Virology 2003;309:248-257.
101. Hyun U, Lee DH, Shin CG. Minimal size of prototype foamy virus integrase for nuclear localization. Acta Virol 2011;55:169-174.
102. Imrich H, Heinkelein M, Herchenröder O, et al. Primate foamy virus Pol proteins are imported into the nucleus. J Gen Virol 2000;81:2941-2947.
103. Johnston PB. A second immunologic type of simian foamy virus: monkey throat infections and unmasking by both types. J Infect Dis 1961;109:1-9.
104. Johnston PB. Taxonomic features of seven serotypes of simian and ape foamy viruses. Infect Immun 1971;3:793-799.
105. Jones-Engel L, May CC, Engel GA, et al. Diverse contexts of zoonotic transmission of simian foamy viruses in Asia. Emerg Infect Dis 2008;14:1200-1208.
106. Jones-Engel L, Steinkraus KA, Murray SM, et al. Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys. J Virol 2007;81:7330-7337.
107. Jordan I, Enssle J, Güttler E, et al. Expression of human foamy virus reverse transcriptase involves a spliced pol mRNA. Virology 1996;224:314-319.
108. Jouvenet N, Neil SJ, Zhadina M, et al. Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin. J Virol 2009;83:1837-1844.
109. Juretzek T, Holm T, Gärtner K, et al. Foamy virus integration. J Virol 2004;78:2472-2477.
110. Kang Y, Blair WS, Cullen BR. Identification and functional characterization of a high-affinity Bel-1 DNA binding site located in the human foamy virus internal promoter. J Virol 1998;72:504-511.
111. Karacostas V, Wolffe EJ, Nagashima K, et al. Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles. Virology 1993;193:661-671.
112. Katzourakis A, Gifford RJ, Tristem M, et al. Macroevolution of complex retroviruses. Science 2009;325:1512.
113. Keller A, Partin KM, Löchelt M, et al. Characterization of the transcriptional trans activator of human foamy retrovirus. J Virol 1991;65:2589-2594.
114. Kennedy-Stoskopf S, Stoskopf MK, Eckhaus MA, et al. Isolation of a retrovirus and a herpesvirus from a captive California sea lion. J Wildl Dis 1986;22:156-164.
115. Khan AS, Kumar D. Simian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans. Transfusion 2006;46:1352-1359.
116. Khan IH, Mendoza S, Yee J, et al. Simultaneous detection of antibodies to six nonhuman-primate viruses by multiplex microbead immunoassay. Clin Vaccine Immunol 2006;13:45-52.
117. Kido K, Bannert H, Gronostajski RM, et al. Bel1-mediated transactivation of the spumaretroviral internal promoter is repressed by nuclear factor I. J Biol Chem 2003;278:11836-11842.
118. Konvalinka J, Löchelt M, Zentgraf H, et al. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol 1995;69:7264-7268.
119. Kretzschmar B, Nowrouzi A, Hartl MJ, et al. AZT-resistant foamy virus. Virology 2008;370:151-157.
120. Krishnan L, Li X, Naraharisetty HL, et al. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc Natl Acad Sci U S A 2010;107:15910-15915.
121. Kupiec JJ, Kay A, Hayat M, et al. Sequence analysis of the simian foamy virus type 1 genome. Gene 1991;101:185-194.
122. Kupiec JJ, Tobaly-Tapiero J, Canivet M, et al. Evidence for a gapped linear duplex DNA intermediate in the replicative cycle of human and simian spumaviruses. Nucleic Acids Res 1988;16:9557-9565.
123. Lecellier CH, Neves M, Giron ML, et al. Further characterization of equine foamy virus reveals unusual features among the foamy viruses. J Virol 2002;76:7220-7227.
124. Lecellier CH, Saib A. Foamy viruses: between retroviruses and pararetroviruses. Virology 2000;271:1-8.
125. Lee CC, Ye F, Tarantal AF. Comparison of growth and differentiation of fetal and adult rhesus monkey mesenchymal stem cells. Stem Cells Dev 2006;15:209-220.
126. Lee EG, Kuppers D, Horn M, et al. A premature termination codon mutation at the C terminus of foamy virus Gag downregulates the levels of spliced pol mRNA. J Virol 2008;82:1656-1664.
127. Lee EG, Linial ML. The C terminus of foamy retrovirus Gag contains determinants for encapsidation of Pol protein into virions. J Virol 2008;82:10803-10810.
128. Leendertz FH, Zirkel F, Couacy-Hymann E, et al. Interspecies transmission of simian foamy virus in a natural predator-prey system. J Virol 2008;82:7741-7744.
129. Lehmann-Che J, Giron ML, Delelis O, et al. Protease-dependent uncoating of a complex retrovirus. J Virol 2005;79:9244-9253.
130. Lehmann-Che J, Renault N, Giron ML, et al. Centrosomal latency of incoming foamy viruses in resting cells. PLoS Pathog 2007;3:e74.
131. Leo B, Hartl M, Schweimer K, et al. Insights into the structure and activity of prototype foamy virus RNase H. Retrovirology 2012;9:14.
132. Leurs C, Jansen M, Pollok KE, et al. Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodeficiency mice repopulating human CD34+ cord blood cells. Hum Gene Ther 2003;14:509-519.
133. Life RB, Lee EG, Eastman SW, et al. Mutations in the amino terminus of foamy virus Gag disrupt morphology and infectivity but do not target assembly. J Virol 2008;82:6109-6119.
134. Lindemann D, Pietschmann T, Picard-Maureau M, et al. A particle-associated glycoprotein signal peptide essential for virus maturation and infectivity. J Virol 2001;75:5762-5771.
135. Lindemann D, Rethwilm A. Characterization of a human foamy virus 170-kilodalton Env-Bet fusion protein generated by alternative splicing. J Virol 1998;72:4088-4094.
136. Lindemann D, Rethwilm A. Foamy virus biology and its application for vector development. Viruses 2011;3:561-585.
137. Linial ML. Foamy viruses are unconventional retroviruses. J Virol 1999;73:1747-1755.
138. Linial ML, Fan H, Hahn B, et al. Retroviridae. In: Fauquet CM, Mayo MA, Maniloff J, et al, eds. Virus Taxonomy. London: Elsevier Academic Press; 2005:421-440.
139. Liu W, Worobey M, Li Y, et al. Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog 2008;4:e1000097.
140. Liu Y, Kim Y, Löchelt M. N-terminally myristoylated feline foamy virus Gag allows Env-independent budding of sub-viral particles. Viruses 2011;3(11):2223-2237.
141. Löchelt M. Foamy virus transactivation and gene expression. Curr Top Microbiol Immunol 2003;277:27-61.
142. Löchelt M, Flügel RM. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol 1996;70:1033-1040.
143. Löchelt M, Flügel RM, Aboud M. The human foamy virus internal promoter directs the expression of the functional Bel 1 transactivator and Bet protein early after infection. J Virol 1994;68:638-645.
144. Löchelt M, Muranyi W, Flügel RM. Human foamy virus genome possesses an internal, Bel-1-dependent and functional promoter. Proc Natl Acad Sci U S A 1993;90:7317-7321.
145. Löchelt M, Romen F, Bastone P, et al. The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein. Proc Natl Acad Sci U S A 2005;102:7982-7987.
146. Löchelt M, Zentgraf H, Flügel RM. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene. Virology 1991;184:43-54.
147. Loh PC, Achong BC, Epstein MA. Further biological properties of the human syncytial virus. Intervirology 1977;8:204-217.
148. Loh PC, Matsuura F, Mizumoto C. Seroepidemiology of human syncytial virus: antibody prevalence in the Pacific. Intervirology 1980;13:87-90.
149. Lüftenegger D, Picard-Maureau M, Stanke N, et al. Analysis and function of prototype foamy virus envelope N glycosylation. J Virol 2005;79:7664-7672.
150. Maertens GN, Hare S, Cherepanov P. The mechanism of retroviral integration from X-ray structures of its key intermediates. Nature 2010;468:326-329.
151. Mahnke C, Kashaiya P, Rössler J, et al. Human spumavirus antibodies in sera from African patients. Arch Virol 1992;123:243-253.
152. Malmquist WA, van der Maaten MJ, Boothe AD. Isolation, immunodiffusion, immunofluroscence, and electron microscopy of a syncytial virus of lymphosarcomatous and apparently normal cattle. Cancer Res 1969;29:188-200.
153. Mannigel I, Stange A, Zentgraf H, et al. Correct capsid assembly mediated by a conserved YXXLGL motif in prototype foamy virus Gag is essential for infectivity and reverse transcription of the viral genome. J Virol 2007;81:3317-3326.
154. Materniak M, Kuzmak J. Poland, personal communication.
155. Matthes D, Wiktorowicz T, Zahn J, et al. Basic residues in the foamy virus Gag protein. J Virol 2011;85:3986-3995.
156. Maurer B, Bannert H, Darai G, et al. Analysis of the primary structure of the long terminal repeat and the gag and pol genes of the human spumaretrovirus. J Virol 1988;62:1590-1591.
157. Maurer B, Serfling E, ter Meulen V, et al. Transcription factor AP-1 modulates the activity of the human foamy virus long terminal repeat. J Virol 1991;65:6353-6357.
158. Meiering CD, Comstock KE, Linial ML. Multiple integrations of human foamy virus in persistently infected human erythroleukemia cells. J Virol 2000;74:1718-1726.
159. Meiering CD, Linial ML. Historical perspective of foamy virus epidemiology and infection. Clin Microbiol Rev 2001;14:165-176.
160. Meiering CD, Linial ML. Reactivation of a complex retrovirus is controlled by a molecular switch and is inhibited by a viral protein. Proc Natl Acad Sci U S A 2002;99:15130-15135.
161. Meiering CD, Linial ML. The promyelocytic leukemia protein does not mediate foamy virus latency in vitro. J Virol 2003;77:2207-2213.
162. Nasimuzzaman M, Persons DA. Cell Membrane-associated heparan sulfate is a receptor for prototype foamy virus in human, monkey, and rodent cells. Mol Ther 2012:20:1158-1166.
163. Meiering CD, Rubio C, May C et al. Cell-type-specific regulation of the two foamy virus promoters. J Virol 2001;75:6547-6557.
164. Mergia A, Blackwell J, Papadi G, et al. Simian foamy virus type 1 (SFV-1) induces apoptosis. Virus Res 1997;50:129-137.
165. Mikovits JA, Hoffman PM, Rethwilm A, et al. In vitro infection of primary and retrovirus-infected human leukocytes by human foamy virus. J Virol 1996;70:2774-2780.
166. Moebes A, Enssle J, Bieniasz PD, et al. Human foamy virus reverse transcription that occurs late in the viral replication cycle. J Virol 1997;71:7305-7311.
167. Müllers E, Stirnnagel K, Kaulfuss S, et al. Prototype foamy virus gag nuclear localization: a novel pathway among retroviruses. J Virol 2011;85:9276-9285.
168. Müllers E, Uhlig T, Stirnnagel K, et al. Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis. J Virol 2011;85:1452-1463.
169. Muranyi W, Flügel RM. Analysis of splicing patterns of human spumaretrovirus by polymerase chain reaction reveals complex RNA structures. J Virol 1991;65:727-735.
170. Murray SM, Picker LJ, Axthelm MK, et al. Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J Virol 2006;80:663-670.
171. Murray SM, Picker LJ, Axthelm MK, et al. Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J Virol 2008;82:5981-5985.
172. Neumann-Haefelin D, Rethwilm A, Bauer G, et al. Characterization of a foamy virus isolated from Cercopithecus aethiops lymphoblastoid cells. Med Microbiol Immunol 1983;172:75-86.
173. Nisole S, Stoye JP, Saib A. TRIM family proteins: retroviral restriction and antiviral defence. Nat Rev Microbiol 2005;3:799-808.
174. Nowrouzi A, Dittrich M, Klanke C, et al. Genome-wide mapping of foamy virus vector integrations into a human cell line. J Gen Virol 2006;87:1339-1347.
175. Ohmine K, Li Y, Bauer TR, et al. Tracking of specific integrant clones in dogs treated with foamy virus vectors. Hum Gene Ther 2011;22:217-224.
176. Pacheco B, Finzi A, McGee-Estrada K, et al. Species-specific inhibition of foamy viruses from South American monkeys by New World Monkey TRIM5α proteins. J Virol 2010;84:4095-4099.
177. Park J, Morrow CD. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production. J Virol 1991;65:5111-5117.
178. Parks WP, Todaro GJ, Scolnick EM, et al. RNA dependent DNA polymerase in primate syncytium-forming (foamy) viruses. Nature 1971;229:258-260.
179. Patton GS, Erlwein O, McClure MO. Cell-cycle dependence of foamy virus vectors. J Gen Virol 2004;85:2925-2930.
180. Patton GS, Morris SA, Chung W, et al. Identification of domains in gag important for prototypic foamy virus egress. J Virol 2005;79:6392-6399.
181. Perkovic M, Schmidt S, Marino D, et al. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J Biol Chem 2009;284:5819-5826.
182. Peters K, Barg N, Gärtner K, et al. Complex effects of foamy virus central purine-rich regions on viral replication. Virology 2008;373:51-60.
183. Peters K, Wiktorowicz T, Heinkelein M, et al. RNA and protein requirements for incorporation of the Pol protein into foamy virus particles. J Virol 2005;79:7005-7013.
184. Petit C, Giron ML, Tobaly-Tapiero J, et al. Targeting of incoming retroviral Gag to the centrosome involves a direct interaction with the dynein light chain 8. J Cell Sci 2003;116:3433-3442.
185. Pfrepper KI, Löchelt M, Rackwitz HR, et al. Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus. J Virol 1999;73:7907-7911.
186. Picard-Maureau M, Jarmy G, Berg A, et al. Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process. J Virol 2003;77:4722-4730.
187. Pietschmann T, Heinkelein M, Heldmann M, et al. Foamy virus capsids require the cognate envelope protein for particle export. J Virol 1999;73:2613-2621.
188. Pietschmann T, Zentgraf H, Rethwilm A, et al. An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J Virol 2000;74:4474-4482.
189. Regad T, Saib A, Lallemand-Breitenbach V, et al. PML mediates the interferon-induced antiviral state against a complex retrovirus via its association with the viral transactivator. EMBO J 2001;20:3495-3505.
190. Renne R, Friedl E, Schweizer M, et al. Genomic organization and expression of simian foamy virus type 3 (SFV-3). Virology 1992;186:597-608.
191. Repaske R, Hartley JW, Kavlick MF, et al. Inhibition of RNase H activity and viral replication by single mutations in the 3' region of Moloney murine leukemia virus reverse transcriptase. J Virol 1989;63:1460-1464.
192. Rethwilm A. Foamy viruses. In: Mahy BWJ, ter Meulen V, eds. Topley & Wilson's Microbiology Virology. London: Edward Arnold; 2005:1304-1321.
193. Rethwilm A. Foamy Viruses. Vol. 277. New York: Springer; 2003.
194. Rethwilm A. Foamy virus vectors: an awaited alternative to gammaretro- and lentiviral vectors. Curr Gene Ther 2007;7:261-271.
195. Rethwilm A. Regulation of foamy virus gene expression. Curr Top Microbiol Immunol 1995;193:1-24.
196. Rethwilm A. Unexpected replication pathways of foamy viruses. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13(Suppl 1):S248-S253.
197. Rethwilm A, Baunach G, Netzer KO, et al. Infectious DNA of the human spumaretrovirus. Nucleic Acids Res 1990;18:733-738.
198. Rethwilm A, Darai G, Rösen A, et al. Molecular cloning of the genome of human spumaretrovirus. Gene 1987;59:19-28.
199. Rethwilm A, Erlwein O, Baunach G, et al. The transcriptional transactivator of human foamy virus maps to the bel 1 genomic region. Proc Natl Acad Sci U S A 1991;88:941-945.
200. Rethwilm A, Lindemann D. Unpublished observations.
201. Rhodes-Feuillette A, Lasneret J, Paulien S, et al. Effects of human recombinant alpha and gamma and of highly purified natural beta interferons on simian Spumavirinae prototype (simian foamy virus 1) multiplication in human cells. Res Virol 1990;141:31-43.
202. Rhodes-Feuillette A, Mahouy G, Lasneret J, et al. Characterization of a human lymphoblastoid cell line permanently modified by simian foamy virus type 10. J Med Primatol 1987;16:277-289.
203. Riggs JL, Oshiro LS, Taylor DO, et al. Syncytium-forming agent isolated from domestic cats. Nature 1969;222:1190-1191.
204. Rinke CS, Boyer PL, Sullivan MD, et al. Mutation of the catalytic domain of the foamy virus reverse transcriptase leads to loss of processivity and infectivity. J Virol 2002;76:7560-7570.
205. Romen F, Backes P, Materniak M, et al. Serological detection systems for identification of cows shedding bovine foamy virus via milk. Virology 2007;364:123-131.
206. Romen F, Pawlita M, Sehr, P et al. Antibodies against Gag are diagnostic markers for feline foamy virus infections while Env and Bet reactivity is undetectable in a substantial fraction of infected cats. Virology 2006;345:502-508.
207. Rosenblum LL, Patton G, Grigg AR, et al. Differential susceptibility of retroviruses to nucleoside analogues. Antivir Chem Chemother 2001;12:91-97.
208. Rösener M, Hahn H, Kranz M, et al. Absence of serological evidence for foamy virus infection in patients with amyotrophic lateral sclerosis. J Med Virol 1996;48:222-226.
209. Roy J, Linial ML. Role of the foamy virus Pol cleavage site in viral replication. J Virol 2007;81:4956-4962.
210. Roy J, Rudolph W, Juretzek T, et al. Feline foamy virus genome and replication strategy. J Virol 2003;77:11324-11331.
211. Rua R, Lepelley A, Gessain A, et al. Innate sensing of foamy viruses by human hematopoietic cells. J Virol 2012;86(2):909-918.
212. Russell RA, Wiegand HL, Moore MD, et al. Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol 2005;79:8724-8731.
213. Rustigian R, Johnston P, Reihart H. Infection of monkey kidney tissue cultures with virus-like agents. Proc Soc Exp Biol Med 1955;88:8-16.
214. Ryabova LA, Hohn T. Ribosome shunting in the cauliflower mosaic virus 35S RNA leader is a special case of reinitiation of translation functioning in plant and animal systems. Genes Dev 2000;14:817-829.
215. Saib A, Neves M, Giron ML, et al. Long-term persistent infection of domestic rabbits by the human foamy virus. Virology 1997;228:263-268.
216. Saib A, Peries J, de The H. A defective human foamy provirus generated by pregenome splicing. EMBO J 1993;12:4439-4444.
217. Saib A, Puvion-Dutilleul F, Schmid M, et al. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol 1997;71:1155-1161.
218. Plochmann K, Horn A, Gschmack E, et al. Heparan sulfate is an attachment factor for foamy virus entry. J Virol 2012:86:10028-10035.
219. Schepetilnikov M, Schott G, Katsarou K, et al. Molecular dissection of the prototype foamy virus (PFV) RNA 5'-UTR identifies essential elements of a ribosomal shunt. Nucleic Acids Res 2009;37:5838-5847.
220. Schliephake AW, Rethwilm A. Nuclear localization of foamy virus Gag precursor protein. J Virol 1994;68:4946-4954.
221. Schmidt M, Herchenröder O, Heeney J, et al. Long terminal repeat U3 length polymorphism of human foamy virus. Virology 1997;230:167-178.
222. Schmidt M, Niewiesk S, Heeney J, et al. Mouse model to study the replication of primate foamy viruses. J Gen Virol 1997;78:1929-1933.
223. Schmidt M, Rethwilm A. Replicating foamy virus-based vectors directing high level expression of foreign genes. Virology 1995;210:167-178.
224. Schrom EM, Schied T, Weitner H, et al. Regulation of foamy virus polyadenylation: major splice donor-mediated suppression at the 5''LTR. 2011 (submitted).
225. Schulze A, Lemey P, Schubert J, et al. Complete nucleotide sequence and evolutionary analysis of a gorilla foamy virus. J Gen Virol 2011;92:582-586.
226. Schweizer M, Falcone V, Gange J, et al. Simian foamy virus isolated from an accidentally infected human individual. J Virol 1997;71:4821-4824.
227. Schweizer M, Fleps U, Jäckle A, et al. Simian foamy virus type 3 (SFV-3) in latently infected Vero cells: reactivation by demethylation of proviral DNA. Virology 1993;192:663-666.
228. Schweizer M, Neumann-Haefelin D. Phylogenetic analysis of primate foamy viruses by comparison of pol sequences. Virology 1995;207:577-582.
229. Schweizer M, Renne R, Neumann-Haefelin D. Structural analysis of proviral DNA in simian foamy virus (LK-3)-infected cells. Arch Virol 1989;109:103-114.
230. Schweizer M, Turek R, Hahn H, et al. Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 1995;11:161-170.
231. Schweizer M, Turek R, Reinhardt M, et al. Absence of foamy virus DNA in Graves' disease. AIDS Res Hum Retroviruses 1994;10:601-605.
232. Shaw KL, Lindemann D, Mulligan MJ, et al. Foamy virus envelope glycoprotein is sufficient for particle budding and release. J Virol 2003;77:2338-2348.
233. Si Y, Pulliam AC, Linka Y, et al. Overnight transduction with foamyviral vectors restores the long-term repopulating activity of Fancc-/- stem cells. Blood 2008;112:4458-4465.
234. Stange A, Lüftenegger D, Reh J, et al. Subviral particle release determinants of prototype foamy virus. J Virol 2008;82:9858-9869.
235. Stange A, Mannigel I, Peters K, et al. Characterization of prototype foamy virus gag late assembly domain motifs and their role in particle egress and infectivity. J Virol 2005;79:5466-5476.
236. Stanke N, Stange A, Lüftenegger D et al. Ubiquitination of the prototype foamy virus envelope glycoprotein leader peptide regulates subviral particle release. J Virol 2005;79:15074-15083.
237. Stenbak CR, Linial ML. Role of the C terminus of foamy virus Gag in RNA packaging and Pol expression. J Virol 2004;78:9423-9430.
238. Stirnnagel K, Lüftenegger D, Stange A, et al. Analysis of prototype foamy virus particle-host cell interaction with autofluorescent retroviral particles. Retrovirology 2010;7:45.
239. Swiersy A, Wiek C, Reh J, et al. Orthoretroviral-like prototype foamy virus Gag-Pol expression is compatible with viral replication. Retrovirology 2011;8:66.
240. Switzer WM, Bhullar V, Shanmugam V, et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 2004;78:2780-2789.
241. Switzer WM, Garcia AD, Yang C, et al. Coinfection with HIV-1 and simian foamy virus in West Central Africans. J Infect Dis 2008;197:1389-1393.
242. Switzer WM, Salemi M, Shanmugam V, et al. Ancient co-speciation of simian foamy viruses and primates. Nature 2005;434:376-380.
243. Tan J, Hao P, Jia R, et al. Identification and functional characterization of BTas transactivator as a DNA-binding protein. Virology 2010;405:408-413.
244. Tan J, Qiao W, Wang J, et al. IFP35 is involved in the antiviral function of interferon by association with the viral tas transactivator of bovine foamy virus. J Virol 2008;82:4275-4283.
245. Tan J, Qiao W, Xu F, et al. Dimerization of BTas is required for the transactivational activity of bovine foamy virus. Virology 2008;376:236-241.
246. Thümer L, Rethwilm A, Holmes EC, et al. The complete nucleotide sequence of a New World simian foamy virus. Virology 2007;369:191-197.
247. Tisdale M, Schulze T, Larder BA, et al. Mutations within the RNase H domain of human immunodeficiency virus type 1 reverse transcriptase abolish virus infectivity. J Gen Virol 1991;72:59-66.
248. Tobaly-Tapiero J, Bittoun P, Giron ML, et al. Human foamy virus capsid formation requires an interaction domain in the N terminus of Gag. J Virol 2001;75:4367-4375.
249. Tobaly-Tapiero J, Bittoun P, Lehmann-Che J, et al. Chromatin tethering of incoming foamy virus by the structural Gag protein. Traffic 2008;9:1717-1727.
250. Tobaly-Tapiero J, Bittoun P, Neves M, et al. Isolation and characterization of an equine foamy virus. J Virol 2000;74:4064-4073.
251. Tobaly-Tapiero J, Kupiec JJ, Santillana-Hayat M, et al. Further characterization of the gapped DNA intermediates of human spumavirus: evidence for a dual initiation of plus-strand DNA synthesis. J Gen Virol 1991;72:605-608.
252. Towers GJ. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007;4:40.
253. Trobridge G, Russell DW. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 2004;78:2327-2335.
254. Trobridge GD. Foamy virus vectors for gene transfer. Expert Opin Biol Ther 2009;9:1427-1436.
255. Trobridge GD, Miller DG, Jacobs MA, et al. Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci U S A 2006;103:1498-1503.
256. Valkov E, Gupta SS, Hare S, et al. Functional and structural characterization of the integrase from the prototype foamy virus. Nucleic Acids Res 2009;37:243-255.
257. Vassilopoulos G, Rethwilm A. Foamy virus vectors: the usefulness of a perfect parasite. Gene Ther 2008;15:1299-1301.
258. Verschoor EJ, Langenhuijzen S, van den Engel S, et al. Structural and evolutionary analysis of an orangutan foamy virus. J Virol 2003;77:8584-8587.
259. Wagner A, Doerks A, Aboud M, et al. Induction of cellular genes is mediated by the Bel1 transactivator in foamy virus-infected human cells. J Virol 2000;74:4441-4447.
260. Wang J, Tan J, Guo H, et al. Bovine foamy virus transactivator BTas interacts with cellular RelB to enhance viral transcription. J Virol 2010;84:11888-11897.
261. Wang JY, Ling H, Yang W, et al. Structure of a two-domain fragment of HIV-1 integrase: implications for domain organization in the intact protein. EMBO J 2001;20:7333-7343.
262. Weaver TA, Talbot KJ, Panganiban AT. Spleen necrosis virus gag polyprotein is necessary for particle assembly and release but not for proteolytic processing. J Virol 1990;64:2642-2652.
263. Wiktorowicz T, Peters K, Armbruster N, et al. Generation of an improved foamy virus vector by dissection of cis-acting sequences. J Gen Virol 2009;90:481-487.
264. Wilk T, de Haas F, Wagner A, et al. The intact retroviral Env glycoprotein of human foamy virus is a trimer. J Virol 2000;74:2885-2887.
265. Wilk T, Geiselhart V, Frech M, et al. Specific interaction of a novel foamy virus Env leader protein with the N-terminal Gag domain. J Virol 2001;75:7995-8007.
266. Winkler I, Bodem J, Haas L, et al. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses. J Virol 1997;71:6727-6741.
267. Winkler IG, Löchelt M, Flower RL. Epidemiology of feline foamy virus and feline immunodeficiency virus infections in domestic and feral cats: a seroepidemiological study. J Clin Microbiol 1999;37:2848-2851.
268. Wu M, Chari S, Yanchis T, et al. cis-Acting sequences required for simian foamy virus type 1 vectors. J Virol 1998;72:3451-3454.
269. Wu Y, Tan J, Su Y, et al. Transcription factor AP1 modulates the internal promoter activity of bovine foamy virus. Virus Res 2010;147:139-144.
270. Xu F, Tan J, Liu R, et al. Tetherin inhibits prototypic foamy virus release. Virol J 2011;8:198.
271. Yap MW, Lindemann D, Stanke N, et al. Restriction of foamy viruses by primate Trim5alpha. J Virol 2008;82:5429-5439.
272. Yu SF, Baldwin DN, Gwynn SR, et al. Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 1996;271:1579-1582.
273. Yu SF, Eastman SW, Linial ML. Foamy virus capsid assembly occurs at a pericentriolar region through a cytoplasmic targeting/retention signal in Gag. Traffic 2006;7:966-977.
274. Yu SF, Edelmann K, Strong RK, et al. The carboxyl terminus of the human foamy virus Gag protein contains separable nucleic acid binding and nuclear transport domains. J Virol 1996;70:8255-8262.
275. Yu SF, Linial ML. Analysis of the role of the bel and bet open reading frames of human foamy virus by using a new quantitative assay. J Virol 1993;67:6618-6624.
276. Yu SF, Stone J, Linial ML. Productive persistent infection of hematopoietic cells by human foamy virus. J Virol 1996;70:1250-1254.
277. Yu SF, Sullivan MD, Linial ML. Evidence that the human foamy virus genome is DNA. J Virol 1999;73:1565-1572.
278. Zamborlini A, Renault N, Saib A, et al. Early reverse transcription is essential for productive foamy virus infection. PLoS One 2010;5:e11023.
279. Zemba M, Wilk T, Rutten T, et al. The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity. Virology 1998;247:7-13.
280. Zenger E, Brown WC, Song W, et al. Evaluation of cofactor effect of feline syncytium-forming virus on feline immunodeficiency virus infection. Am J Vet Res 1993;54:713-718.
281. Zhadina M, Bieniasz PD. Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. PLoS Pathog 2010;6:e1001153.
282. Zhadina M, McClure MO, Johnson MC, et al. Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci U S A 2007;104:20031-20036.
283. Zou JX, Luciw PA. The transcriptional transactivator of simian foamy virus 1 binds to a DNA target element in the viral internal promoter. Proc Natl Acad Sci U S A 1996;93:326-330.